查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球计量原子吸入器市场——行业分析、规模、份额、增长、趋势和预测，2022-2031 年
市场调查报告书
商品编码
1229577

全球计量原子吸入器市场——行业分析、规模、份额、增长、趋势和预测，2022-2031 年

Metered Dose Inhalers Market (Product Type: Manual Actuated pMDIs and Breath Actuated pMDIs; Disease Indication: Asthma, COPD, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 216 Pages | 商品交期: 2-10个工作天内

价格

以 2022 年为基准年，2031 年为预测年，本报告介绍了 2017 年至 2031 年全球计量吸入器市场的收入。它还介绍了 2022 年至 2031 年全球计量吸入器市场的复合年增长率 (CAGR %)。

本报告是广泛研究的结果。在初步研究中，分析师对主要思想领袖、行业领袖和舆论製造者进行了访谈，开展了大量研究工作。在二次研究中，我们通过参考主要公司的产品资料、年报、新闻稿和相关文件确定了计量吸入器市场。

该报告深入探讨了全球计量吸入器市场的竞争格局。已经确定了在全球计量吸入器市场运营的主要参与者，并且对这些公司中的每一家都进行了不同属性的分析。公司概况、财务状况、近期发展和 SWOT 是本报告中介绍的全球计量吸入器市场参与者的属性。

目录

第一章 前言

  • 市场定义和范围
  • 市场细分
  • 主要研究目的
  • 调查亮点

第二章前提条件和研究方法

3. 执行摘要：计量吸入器的全球市场

第四章市场概况

  • 介绍
    • 定义
    • 行业的演变与发展
  • 概述
  • 市场动态
    • 促进者
    • 抑製剂
    • 机会
  • 2017-2031 年全球计量吸入器市场分析与预测
    • 市场收入预测
  • 波特五力分析

第 5 章关键见解

  • 呼吸道疾病流行病学
  • 技术进步
  • 重大併购（Merger/Acquisition
  • COVID-19 大流行对行业的影响（价值炼和短期、中期和长期影响）。

第六章按产品类型分列的计量原子吸入器的全球市场分析与预测

  • 介绍和定义
  • 重大发现/发展
  • 2017-2031 年按产品类型划分的市场价值预测
    • 手动pMDI
    • 呼吸致动器 pMDI
  • 市场吸引力分析：按产品类型

第七章按适应症分列的计量吸入器全球市场分析与预测

  • 介绍和定义
  • 重大发现/发展
  • 市场价值预测：按疾病适应症分类，2017-2031 年
    • 支气管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 市场吸引力分析：按疾病和适应症

8 全球计量原子吸入器市场分析及分销渠道预测

  • 介绍和定义
  • 重大发现/发展
  • 2017-2031 年各分销渠道的市场价值预测
    • 医院药房
    • 零售药店
    • 在线药店
  • 市场吸引力分析：按分销渠道

第 9 章按地区分列的计量原子吸入器的全球市场分析和预测

  • 主要发现
  • 2017-2031 年各地区市场价值预测
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲
  • 市场吸引力分析：按地区

第 10 章北美计量原子吸入器市场分析与预测

  • 介绍
    • 主要发现
  • 2017-2031 年按产品类型划分的市场价值预测
    • 手动pMDI
    • 呼吸致动器 pMDI
  • 市场价值预测：按疾病适应症分类，2017-2031 年
    • 支气管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分销渠道的市场价值预测
    • 医院药房
    • 零售药店
    • 在线药店
  • 市场价值预测：按国家/地区划分，2017-2031 年
    • 美国
    • 加拿大
  • 市场吸引力分析
    • 按产品类型
    • 按疾病 按适应症
    • 按分销渠道
    • 按国家

第 11 章欧洲计量吸入器市场分析与预测

  • 介绍
    • 主要发现
  • 2017-2031 年按产品类型划分的市场价值预测
    • 手动pMDI
    • 呼吸致动器 pMDI
  • 市场价值预测：按疾病适应症分类，2017-2031 年
    • 支气管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分销渠道的市场价值预测
    • 医院药房
    • 零售药店
    • 在线药店
  • 2017-2031 年按国家/地区划分的市场价值预测
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 市场吸引力分析
    • 按产品类型
    • 按疾病 按适应症
    • 按分销渠道
    • 按国家/地区

第 12 章亚太计量原子吸入器市场分析与预测

  • 介绍
    • 主要发现
  • 2017-2031 年按产品类型划分的市场价值预测
    • 手动pMDI
    • 呼吸致动器 pMDI
  • 市场价值预测：按疾病适应症分类，2017-2031 年
    • 支气管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分销渠道的市场价值预测
    • 医院药房
    • 零售药店
    • 在线药店
  • 2017-2031 年按国家/地区划分的市场价值预测
    • 中国
    • 日本
    • 印度
    • 澳大利亚/新西兰
    • 亚太其他地区
  • 市场吸引力分析
    • 按产品类型
    • 按疾病 按适应症
    • 按分销渠道
    • 按国家/地区

第 13 章拉丁美洲计量原子吸入器市场分析与预测

  • 介绍
    • 主要发现
  • 2017-2031 年按产品类型划分的市场价值预测
    • 手动pMDI
    • 呼吸致动器 pMDI
  • 市场价值预测：按疾病适应症分类，2017-2031 年
    • 支气管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分销渠道的市场价值预测
    • 医院药房
    • 零售药店
    • 在线药店
  • 2017-2031 年按国家/地区划分的市场价值预测
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 市场吸引力分析
    • 按产品类型
    • 按疾病 按适应症
    • 按分销渠道
    • 按国家/地区

第 14 章中东和非洲计量原子吸入器市场分析与预测

  • 介绍
    • 主要发现
  • 2017-2031 年按产品类型划分的市场价值预测
    • 手动pMDI
    • 呼吸致动器 pMDI
  • 市场价值预测：按疾病适应症分类，2017-2031 年
    • 支气管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分销渠道的市场价值预测
    • 医院药房
    • 零售药店
    • 在线药店
  • 2017-2031 年按国家/地区划分的市场价值预测
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区
  • 市场吸引力分析
    • 按产品类型
    • 按疾病 按适应症
    • 按分销渠道
    • 按国家/地区

第十五章竞争格局

  • 市场竞争对手 - 竞争矩阵（按层级，按公司规模）
  • 市场份额分析：按公司分类（2021 年）
  • 公司简介
    • AstraZeneca
    • Cipla Limited
    • Novartis AG
    • Merck & Co., Inc.
    • Sanofi
    • Boehringer Ingelheim
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Hikma Pharmaceuticals plc
    • GlaxoSmithKline
Product Code: TMRGL32174

The report provides revenue of the global metered dose inhalers market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global metered dose inhalers market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the metered dose inhalers market.

The report delves into the competitive landscape of the global metered dose inhalers market. Key players operating in the global metered dose inhalers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global metered dose inhalers market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Metered Dose Inhalers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Metered Dose Inhalers Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Forces Analysis

5. Key Insights

  • 5.1. Respiratory Disease Epidemiology
  • 5.2. Technological Advancements
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Metered Dose Inhalers Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Manual Actuated pMDIs
    • 6.3.2. Breath Actuated pMDIs
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Metered Dose Inhalers Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 7.3.1. Asthma
    • 7.3.2. COPD
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Disease Indication

8. Global Metered Dose Inhalers Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Metered Dose Inhalers Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Metered Dose Inhalers Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Manual Actuated pMDIs
    • 10.2.2. Breath Actuated pMDIs
  • 10.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 10.3.1. Asthma
    • 10.3.2. COPD
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Disease Indication
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Metered Dose Inhalers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Manual Actuated pMDIs
    • 11.2.2. Breath Actuated pMDIs
  • 11.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 11.3.1. Asthma
    • 11.3.2. COPD
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Disease Indication
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Metered Dose Inhalers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Manual Actuated pMDIs
    • 12.2.2. Breath Actuated pMDIs
  • 12.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 12.3.1. Asthma
    • 12.3.2. COPD
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Disease Indication
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Metered Dose Inhalers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Manual Actuated pMDIs
    • 13.2.2. Breath Actuated pMDIs
  • 13.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 13.3.1. Asthma
    • 13.3.2. COPD
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Disease Indication
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Metered Dose Inhalers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Manual Actuated pMDIs
    • 14.2.2. Breath Actuated pMDIs
  • 14.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 14.3.1. Asthma
    • 14.3.2. COPD
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Disease Indication
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. AstraZeneca
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Type Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Cipla Limited
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Type Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Novartis AG
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Type Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Merck & Co., Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Type Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Sanofi
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Type Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. Boehringer Ingelheim
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Type Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. Teva Pharmaceutical Industries Ltd.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Type Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Mylan N.V.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Type Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. Hikma Pharmaceuticals plc
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Type Portfolio
      • 15.3.9.3. Financial Overview
    • 15.3.10. GlaxoSmithKline
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Type Portfolio
      • 15.3.10.3. Financial Overview

List of Tables

  • Table 01: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 03: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 08: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 11: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 12: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 16: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 20: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 24: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Metered Dose Inhalers Market Value Share, by Product Type, 2021
  • Figure 03: Global Metered Dose Inhalers Market Value Share, by Distribution Channel, 2021
  • Figure 04: Global Metered Dose Inhalers Market Value Share, by Disease Indication, 2021
  • Figure 05: Global Metered Dose Inhalers Market Value Share, by Region, 2021
  • Figure 06: Global Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 07: Global Metered Dose Inhalers Market Value (US$ Mn), by Manual Actuated pMDIs, 2017-2031
  • Figure 08: Global Metered Dose Inhalers Market Value (US$ Mn), by Breath Actuated pMDIs, 2017-2031
  • Figure 09: Global Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 10: Global Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 11: Global Metered Dose Inhalers Market Value (US$ Mn), by Asthma, 2017-2031
  • Figure 12: Global Metered Dose Inhalers Market Value (US$ Mn), by COPD, 2017-2031
  • Figure 13: Global Metered Dose Inhalers Market Value (US$ Mn), by Others, 2017-2031
  • Figure 14: Global Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 15: Global Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 16: Global Metered Dose Inhalers Market Value (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 17: Global Metered Dose Inhalers Market Value (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 18: Global Metered Dose Inhalers Market Value (US$ Mn), by Online Pharmacies, 2017-2031
  • Figure 19: Global Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 20: Global Metered Dose Inhalers Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 21: Global Metered Dose Inhalers Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 22: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 23: North America Metered Dose Inhalers Market Value Share (%), by Country, 2021 and 2031
  • Figure 24: North America Metered Dose Inhalers Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 25: North America Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 26: North America Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 27: North America Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 28: North America Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 29: North America Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 30: North America Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 31: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 32: Europe Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 33: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 34: Europe Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 35: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 36: Europe Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 37: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 38: Europe Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 39: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 40: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 41: Asia Pacific Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 42: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 44: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 45: Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 46: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 47: Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 48: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 49: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 50: Latin America Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 51: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 52: Latin America Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 53: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 54: Latin America Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 55: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 56: Latin America Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 57: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 58: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 59: Middle East & Africa Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 60: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 61: Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 62: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 63: Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 64: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 65: Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 66: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 67: Global Metered Dose Inhalers Market Share Analysis, by Company, 2021